Focusing on the more numerous DDX3X mutations, among virus-positive tumor samples they were detected in 49% (67/136) BL, 29% (4/14) ANKL, 19% (19/100) NKTCL, 1.2% (1/86) cHL, 5% (4/81) ATL, 3% (1/30) PBL, 3% (2/60) HNSCC, and 2% (3/144) of CC. The gene discussed is DDX3X; the disease is head and neck squamous cell carcinoma.